Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®
-
Northstar Completes Emission Reduction Alberta Construction Milestone and Receives $3.9 Million
-
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025
-
Apollo Silver Appoints Ross McElroy as President and CEO
-
Aircastle Announces $600 million Unsecured Financing Facility
-
Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September
-
Employers face rising healthcare costs from climate risks and new forecasting tool helps them assess the impact
-
LUCA DISCOVERS MULTIPLE NEW HIGH-GRADE ORE SHOOTS AT TAHUEHUETO MINE, DURANGO, MEXICO
-
Safeguard Global Unveils Brand Evolution Focused on Expert-Led Global Expansion
-
NAPCO Security Technologies, Inc. Reports Fiscal 2025 Third Quarter Results
-
PLBY Group to Report First Quarter 2025 Financial Results on May 15, 2025
-
Welcome Home: Vivint Debuts New Brand Identity, Signaling a New Era in Smart Home
-
Tatte Bakery and Café Opens First Location in New Jersey
-
Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
-
Local Snapshot: Half Of U.S. Small Businesses Change Strategies Amid Macro-Economic Challenges, Chase Survey Finds
-
Thoma Bravo Announces More Than $100M Strategic Growth Investment in HubSync
-
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
-
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR MAY 2025
-
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025
-
Nexstar Media Group Declares Quarterly Cash Dividend of $1.86 Per Share
-
DoorDash Announces Date and Time Change of First Quarter 2025 Financial Results and Conference Call
-
Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera
-
Joey Chestnut to Attempt Popcorn World Record at Rural King This Memorial Day Weekend
-
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
-
Aptose Provides Clinical Update for the Tuspetinib-based Triple Drug Frontline Therapy in Newly Diagnosed AML Patients from the Phase 1/2 TUSCANY Trial
-
Routeware Celebrates 25 Years of Transformation in Waste Management Technology
-
Elliott Fails to Address Key Investor Questions
-
Angel Oak Mortgage REIT, Inc. Reports First Quarter 2025 Financial Results
-
WESTERN MIDSTREAM ANNOUNCES APPOINTMENT OF ROBERT G. PHILLIPS AS INDEPENDENT DIRECTOR
-
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
-
World Ovarian Cancer Coalition Leads Global Campaign to Raise Awareness of Ovarian Cancer
-
Partners Capital Appoints Andy Canovali as Managing Director, Head of Secondaries
-
Vision Government Solutions Completes Recapitalization with Great Hill Partners
-
monday.com Announces Participation in the J.P. Morgan Global Technology, Media and Communications Conference
-
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th
-
Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company
-
Mobilicom’s Cybersecure Drone and Robotics Solutions to Feature at Key U.S. Defense & Autonomy Industry Events
-
Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
-
Grassy Mountain Gold Project Selected for US Government FAST-41 Program
-
ManageMy and Solvrays Enable Insurance Carriers to Automate Workflows and Deliver Better Customer Experiences
-
Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI
-
AAFA Calls on Congress to Restore Lifesaving National Asthma Control Program
-
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of
-
Algorhythm Holdings Acquires SemiCab India, Expands Global AI Transportation Footprint
-
ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model
-
GXO and Blue Yonder Announce New Strategic Global Agreement
-
EnviroGold Global Announces Appointment of Paul McRae as Non-Executive Chair
-
Colliers adds leading telecommunications engineering firm
-
Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
-
Aquestive Therapeutics to Participate in Citizens Life Sciences Conference

